In compliance with the Company’s Code of Conduct for Prevention of Insider Trading, Sun Pharmaceutical Industries has informed that the window for trading in the securities of the Company by Designated Persons of the Company (along with his/her immediate relatives or any person with whom he/she shares a material financial relationship), shall remain closed from Saturday, July 1, 2023 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ending June 30, 2023. The date of the Board Meeting of the Company for declaration of the Unaudited Financial Results of the Company for the quarter ending June 30, 2023 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: